A pilot randomised controlled trial of the Sleeping Sound Intervention on children's sleep difficulties in children with Autism Spectrum Disorder and Intellectual Disability.

Dr Nicole Papadopoulos0 sites11 target enrollmentApril 20, 2018

Overview

No summary available.

Registry

who.int

Start Date

April 20, 2018

End Date

February 12, 2020

Last Updated

5 years ago

Study Type

Interventional

Sex

All

Sponsor

Dr Nicole Papadopoulos

•Parents of children who meet the following criteria will be eligible:
•\* Diagnosis of DSM\-IV Autistic Disorder, Asperger’s Disorder or DSM\-5 ASD, as indicated by paediatrician or a confirmed diagnosis as cited in a clinical report AND
•Aged 6\-13 years AND
•A score above the clinical cut off (11 or more) on the Social Communication Questionnaire Lifetime form (10 minutes completion time) AND
•Having a moderate or severe sleep problem by parent report and need to meet criteria for at least one of the following behavioural sleep problems as defined by the American Academy of Sleep Medicine diagnostic criteria: chronic insomnia (due to problems of sleep onset association, limit setting, prolonged night time waking, primary insomnia, early waking, or anxiety) delayed sleep phase disorder AND
•Child has an intellectual disability which will be confirmed by citing a diagnostic/clinical report.
•Participants currently taking melatonin as well as any other medications (SSRI’s etc.) will be included in the trial, if they continue to meet the above eligibility criteria. Information regarding medication will be collected as part of the survey.

•Participants will be excluded if their child has restless leg syndrome or any comorbid medical (e.g., tuberous sclerosis, epilepsy), neuropsychiatric (e.g., Tourette’s) or genetic (e.g., Fragile X disorder) conditions. Non\-English speaking families will be excluded. Parents will be excluded if their child has obstructive sleep apnoea.